ABSTRACT
OBJECTIVE: To assess longitudinal expression of a proliferation-inducing ligand (APRIL) in patients with systemic lupus erythematosus (SLE) and its correlation with B lymphocyte stimulator (BLyS) expression, serum anti-dsDNA titres, and clinical disease activity. METHODS: Sixty eight patients with SLE were longitudinally followed up for a median of 369 days. At each visit the physician assessed disease activity by SLEDAI, and blood was collected for determination of serum APRIL and BLyS levels and of blood APRIL and BLyS mRNA levels. Fifteen normal control subjects underwent similar laboratory evaluation. RESULTS: Dysregulation of APRIL was not as great as that of BLyS. Changes in serum levels of APRIL and BLyS over time were usually discordant, whereas blood levels of APRIL and BLyS mRNA strongly paralleled each other. Serum APRIL levels modestly, but significantly, inversely correlated with serum anti-dsDNA titres in anti-dsDNA positive patients analysed in aggregate. Moreover, serum APRIL levels modestly, but significantly, inversely correlated with clinical disease activity in all patients analysed in aggregate. CONCLUSION: Serum levels of APRIL and BLyS are differentially regulated. APRIL may serve as a down modulator of serological and/or clinical autoimmunity in patients with SLE. This may have important ramifications for BLyS targeted treatment, and it remains to be determined whether agents which neutralise only BLyS will be preferable to agents which neutralise both BLyS and APRIL.
Subject(s)
Lupus Erythematosus, Systemic/blood , Neuropeptides/blood , Nuclear Proteins/blood , Antibodies, Antinuclear/blood , B-Cell Activating Factor , DNA/immunology , Follow-Up Studies , Humans , Membrane Proteins/blood , Membrane Proteins/genetics , Neuropeptides/genetics , Nuclear Proteins/genetics , RNA, Messenger/blood , Tumor Necrosis Factor-alpha/geneticsABSTRACT
Adhesive tape strip and dry swab sampling techniques were compared for the detection of Malassezia pachydermatis on the skin of dogs with chronic dermatitis. One hundred and four dogs were sampled by each of the techniques. Two methods, a culture method and a stain method, were used to assess the sampling techniques. By the adhesive tape strip sampling technique, M. pachydermatis was detected on 83 (80%) dogs using the culture method and on 45 (43%) dogs using the stain method. By the dry swab sampling technique, M. pachydermatis was detected on 55 (53%) dogs using the culture method and on 33 (32%) dogs using the stain method. The study showed that the adhesive tape strip sampling technique, using the culture method, detected Malassezia on the skin of significantly more dogs (P<0.001) than the same technique using the stain method and also significantly more than the dry swab sampling technique, using either the culture or stain methods. It was also shown that an adhesive tape sample could be used to transfer cells to a slide for staining and microscopy prior to being used for culturing Malassezia.
Subject(s)
Dermatitis/veterinary , Dermatomycoses/veterinary , Dog Diseases/microbiology , Malassezia/isolation & purification , Adhesives , Animals , Dermatitis/microbiology , Dermatomycoses/diagnosis , Dog Diseases/diagnosis , Dogs , Female , Male , Specimen HandlingABSTRACT
Increased levels of B lymphocyte stimulator (BLyS) are associated with systemic autoimmunity in animal models of spontaneous autoimmune disease, and transgenic animals expressing BLyS develop typical autoimmune disease. Here, we demonstrate significant elevations of BLyS in the patients with systemic lupus erythematosus (SLE). The BLyS isolated from the sera of SLE patients had the same m.w. as the natural soluble form and was able to stimulate B cell activation in vitro. Increased BLyS in SLE patients was partially associated with higher levels of anti-dsDNA Ab of the IgG, IgM, and IgA classes, but not associated with the disease activity. Our results suggest that BLyS may be a useful marker for early activation of an autoimmune diathesis and likely plays a critical role in triggering activation of self-Ag-driven autoimmune B cells in human SLE. BLyS may provide an effective therapeutic target in systemic autoimmunity.
Subject(s)
B-Lymphocytes/immunology , Lupus Erythematosus, Systemic/immunology , Lymphocyte Activation/immunology , Membrane Proteins/physiology , Tumor Necrosis Factor-alpha/physiology , Animals , Antibodies, Antinuclear/biosynthesis , Antibodies, Antinuclear/blood , B-Cell Activating Factor , Cells, Cultured , DNA/immunology , Humans , Lupus Erythematosus, Systemic/blood , Membrane Proteins/biosynthesis , Membrane Proteins/blood , Mice , Mice, Inbred BALB C , Tumor Necrosis Factor-alpha/biosynthesisABSTRACT
An expression cloning approach was employed to identify the receptor for B-lymphocyte stimulator (BLyS) and identified the tumor necrosis factor receptor superfamily member TACI as a BLyS-binding protein. Expression of TACI in HEK293T cells confers on the cells the ability to bind BLyS with subnanomolar affinity. Furthermore, a TACI-Fc fusion protein recognizes both the cleaved, soluble form of BLyS as well as the membrane BLyS present on the cell surface of a recombinant cell line. TACI mRNA is found predominantly in B-cells and correlates with BLyS binding in a panel of B-cell lines. We also demonstrate that TACI interacts with nanomolar affinity with the BLyS-related tumor necrosis factor homologue APRIL for which no clear in vivo role has been described. BLyS and APRIL are capable of signaling through TACI to mediate NF-kappaB responses in HEK293 cells. We conclude that TACI is a receptor for BLyS and APRIL and discuss the implications for B-cell biology.
Subject(s)
B-Lymphocytes/physiology , Membrane Proteins , Neuropeptides/physiology , Nuclear Proteins/physiology , Receptors, Tumor Necrosis Factor/physiology , Tumor Necrosis Factor-alpha/chemistry , B-Cell Activation Factor Receptor , B-Lymphocytes/metabolism , Cell Line , Cell Membrane/metabolism , DNA, Complementary/metabolism , Dose-Response Relationship, Drug , Flow Cytometry , Gene Library , Humans , Kinetics , Ligands , Polymerase Chain Reaction , Protein Binding , RNA, Messenger/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Recombinant Fusion Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , Time Factors , Transfection , Transmembrane Activator and CAML Interactor ProteinSubject(s)
Certification , Dermatology , Veterinary Medicine/standards , Animals , Humans , Ireland , United KingdomABSTRACT
The tumor necrosis factor (TNF) and TNF receptor (TNFR) gene superfamilies regulate diverse biological functions, including cell proliferation, differentiation, and survival [1] [2] [3]. We have identified a new TNF-related ligand, designated human GITR ligand (hGITRL), and its human receptor (hGITR), an ortholog of the recently discovered murine glucocorticoid-induced TNFR-related (mGITR) protein [4]. The hGITRL gene mapped to chromosome 1q23, near the gene for the TNF homolog Fas/CD95 ligand [5]. The hGITR gene mapped to chromosome 1p36, near a cluster of five genes encoding TNFR homologs [1] [6]. We found hGITRL mRNA in several peripheral tissues, and detected hGITRL protein on cultured vascular endothelial cells. The levels of hGITR mRNA in tissues were generally low; in peripheral blood T cells, however, antigen-receptor stimulation led to a substantial induction of hGITR transcripts. Cotransfection of hGITRL and hGITR in embryonic kidney 293 cells activated the anti-apoptotic transcription factor NF-kappaB, via a pathway that appeared to involve TNFR-associated factor 2 (TRAF2) [7] and NF-kappaB-inducing kinase (NIK) [8]. Cotransfection of hGITRL and hGITR in Jurkat T leukemia cells inhibited antigen-receptor-induced cell death. Thus, hGITRL and hGITR may modulate T lymphocyte survival in peripheral tissues.
Subject(s)
Chromosomes, Human, Pair 1 , Receptors, Nerve Growth Factor/genetics , Receptors, Tumor Necrosis Factor/genetics , Transcription, Genetic , Tumor Necrosis Factor-alpha/genetics , Amino Acid Sequence , Animals , Cell Line , Cells, Cultured , Chromosome Mapping , Endothelium, Vascular/metabolism , Gene Expression Regulation , Glucocorticoid-Induced TNFR-Related Protein , Humans , Mice , Molecular Sequence Data , Multigene Family , Proteins/metabolism , RNA, Messenger/analysis , Receptors, Nerve Growth Factor/chemistry , Receptors, Nerve Growth Factor/physiology , Receptors, Tumor Necrosis Factor/chemistry , Receptors, Tumor Necrosis Factor/physiology , Recombinant Proteins/biosynthesis , Sequence Alignment , Sequence Homology, Amino Acid , Signal Transduction , TNF Receptor-Associated Factor 2 , Transfection , Tumor Necrosis Factor-alpha/chemistryABSTRACT
We have cloned and sequenced novel cDNAs that encode human and murine DNase II, the acidic deoxyribonuclease. Sequence analysis predicts that huDNase II contains an N-terminal signal sequence and that mature DNase II has 344 residues with a calculated molecular mass of 38 032 Da. DNase II is a novel enzyme with no homologies to proteins of known function. Surprisingly, C. elegans appears to possess a family of DNase II homologs. Unlike DNase I-like enzymes that have tissue-specific expression patterns, huDNase II is ubiquituously expressed at low levels. When huDNase II is expressed in human 293 cells, we observe secretion of a novel 42-44 kDa glycoprotein; approximately 20-30% of recombinant human DNase II activity is secreted in this system. The secreted enzyme possesses DNA hydrolytic activity and shares biochemical properties with purified DNase II obtained from other species. We also show that the mechanism by which DNase II cuts DNA is similar to DNase I in that the enzyme produces nicks rather than double-strand cuts.
Subject(s)
Endodeoxyribonucleases/genetics , Endodeoxyribonucleases/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Cloning, Molecular , Endodeoxyribonucleases/chemistry , Humans , Kidney , Kinetics , Mice , Molecular Sequence Data , Oligonucleotide Probes , Peptide Fragments/chemistry , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Restriction Mapping , Sequence Alignment , Sequence Homology, Amino Acid , Swine , TransfectionABSTRACT
We have cloned human and murine DNase I-like cDNAs, termed LS-DNase, which are expressed at high levels in liver and spleen tissues. LS-DNase expression is highly specific to macrophage populations within these and other tissues. Mature LS-DNase from both species is a secreted, non-glycosylated protein containing 285 residues, with a calculated molecular mass of 33 kDa and a basic isoelectric point. Human and murine LS-DNase are highly conserved and share 83% identity. Sequence analysis reveals that LS-DNase shares 46% amino acid sequence identity with DNase I. However, several residues identified as important for interaction of human DNase I with actin are not conserved in both human and murine LS-DNase. Consistent with this observation, recombinant human LS-DNase possesses a DNA hydrolytic activity which, unlike DNase I, is not inhibited by G-actin. The existence of a family of DNase I-like molecules that have tissue-specific expression patterns and the possible role of a macrophage specific DNase are discussed.
Subject(s)
Endodeoxyribonucleases/genetics , Macrophages/enzymology , Actins/metabolism , Adult , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Cloning, Molecular , DNA Primers , Deoxyribonuclease I/metabolism , Endodeoxyribonucleases/biosynthesis , Endodeoxyribonucleases/chemistry , Female , Gene Expression Regulation, Enzymologic , Humans , Kidney , Liver/cytology , Liver/enzymology , Male , Mice , Molecular Sequence Data , Oligonucleotide Probes , Organ Specificity , Polymerase Chain Reaction , Pregnancy , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Sequence Alignment , Sequence Homology, Amino Acid , Spleen/cytology , Spleen/enzymology , TransfectionABSTRACT
A colony of Ctenocephalides canis was established using dogs as hosts. Two diets were used as media. Fleas reared on cats did not develop beyond the first larval stages. The effects of different temperatures on egg hatching and larval development were examined. Larval survival was poor at 22 degrees C and 25 degrees C at 50% relative humidity, but good at 75% relative humidity at these temperatures. The development from egg to adult took 21 days.
Subject(s)
Dog Diseases/parasitology , Ectoparasitic Infestations/veterinary , Siphonaptera/growth & development , Animals , Dogs , Ectoparasitic Infestations/parasitology , Humidity , Larva/growth & development , Pupa/growth & development , TemperatureABSTRACT
The chlA locus encodes functions required for the biosynthesis of the molybdopterin part of the molybdenum cofactor. Mutants, carrying gene fusions at the chlA locus, which place beta-galactosidase expression under the control of the chlA promoter, have been isolated employing lambda placMu1 as the mutagen. The mutants exhibited beta-galactosidase expression which was greatly enhanced when grown anaerobically. Secondary mutations at the chlB, D, E or G loci did not affect the high level of expression. The fnr gene product was not required for the anaerobic expression. Bacteriophage lambda transducing phages were isolated which carried the phi(chlA-lac) mutations and were used to construct chlA+/phi(clA-lac) merodiploids. The merodiploids exhibited a much lower level of expression but showed the same characteristics as strains carrying lac fusions to the single chromosomal chlA locus. Genetic evidence is presented which strongly suggests that the molybdenum cofactor is a repressor of chlA expression. The anaerobic enhancement of chlA expression is mediated via a mechanism that is distinct from the molybdenum cofactor effect.
Subject(s)
Coenzymes , Escherichia coli/genetics , Gene Expression Regulation, Bacterial , Metalloproteins/metabolism , Molybdenum/metabolism , Pteridines/metabolism , Anaerobiosis , Chlorates/pharmacology , Drug Resistance, Microbial , Molybdenum Cofactors , Mutation/genetics , Nitrate Reductase , Nitrate Reductases/genetics , Recombinant Fusion Proteins/biosynthesis , beta-Galactosidase/geneticsABSTRACT
Only five mitochondrial proteins are known to be essential for viability of the yeast Saccharomyces cerevisiae; all of them are key components of the mitochondrial protein import system. Other components of this system are not essential for life; they include functionally redundant import receptors on the mitochondrial surface and enzymes acting upon only a few precursor proteins.
Subject(s)
Carrier Proteins/physiology , Mitochondria/metabolism , Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Biological Transport/genetics , Cell Survival/genetics , Fungal Proteins/metabolismABSTRACT
The gene encoding ISP42, an integral outermembrane protein located at the yeast mitochondrial protein import site was cloned, sequenced and modified. Yeast cells depleted of ISP42 accumulate uncleaved mitochondrial precursor proteins and then die. ISP42 is the first mitochondrial membrane protein shown to be indispensable for protein import and cell viability.
Subject(s)
Fungal Proteins/genetics , Genes, Fungal , Membrane Transport Proteins , Mitochondria/metabolism , Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae/genetics , Amino Acid Sequence , Base Sequence , Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology , Fungal Proteins/metabolism , Kinetics , Membrane Proteins/genetics , Mitochondrial Membrane Transport Proteins , Molecular Sequence Data , Restriction Mapping , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/growth & developmentABSTRACT
Signal and stop-transfer sequences are the known determinants involved in topogenesis of integral membrane proteins. To study the characteristics of stop-transfer sequences, artificial proteins have been created on the DNA level based on the cDNA of the asialoglycoprotein receptor H1. Its internal signal/anchor domain initiates translocation of the downstream sequence across the endoplasmic reticulum membrane. The ability of several hydrophobic sequences inserted into the translocating polypeptide to stop further transfer was analyzed by translation of the fusion proteins using the wheat germ extract and rabbit reticulocyte lysate systems with dog pancreas microsomes. We discovered that some of the sequences behave differently with respect to translocation across the membrane depending on the translation system. Expression of one of the fusion proteins in fibroblasts showed that the reticulocyte lysate system reflects more closely the in vivo situation than the wheat germ system. Our results suggest that in a homologous system the translating ribosomes interact with the translocation machinery and influence the termination of polypeptide transfer by hydrophobic sequences.